EM || Cardiology

FDA rejects serelaxin for acute heart failure

Posted on: 16/05/2014 - 21:45

The Food and Drug Administration has decided that more evidence of serelaxin’s efficacy as a treatment for acute heart failure is needed before the drug can be approved in the United States, Novartis...

Field of Interest: Cardiology
Type: News Item

RAS blocker prescriptions still lag for ACS patients

Posted on: 25/02/2014 - 21:00

Fifteen percent of eligible patients treated for acute coronary syndrome still are not given ACE inhibitors or angiotensin receptor blockers as recommended, according to data from a quality...

Field of Interest: Cardiology
Type: News Item

No ACS approvals for rivaroxaban, Janssen announces

Posted on: 14/02/2014 - 18:10

As expected, the Food and Drug Administration has declined to approve the oral anticoagulant rivaroxaban for treating acute coronary syndromes. The manufacturer of the factor Xa inhibitor, Janssen...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness